HolderBook

BIOCEPT INC (BIOCQ)

Institutional ownership reported to the SEC as of Q3 2023, across 11 quarters.

11
Reporting holders
$201.0K
Reported value
0.0%
Held as options
+2
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
Alyeska Investment Group, L.P.$147.1K117,6470.00%newNEW
TWO SIGMA SECURITIES, LLC$15.9K12,7180.00%newNEW
GEODE CAPITAL MANAGEMENT, LLC$13.1K10,5040.00%newNEW
SUSQUEHANNA INTERNATIONAL GROUP, LLP$13.0K10,4060.00%newNEW
BlackRock Inc.$6.6K5,2610.00%2qHELD
Tower Research Capital LLC (TRC)$4.8K3,8020.00%2q-29.4%-$2.0K
GROUP ONE TRADING, L.P.$3382700.00%2qHELD
UBS Group AG$1551240.00%newNEW
OSAIC HOLDINGS, INC.$41330.00%2qHELD
US BANCORP \DE\$23180.00%2qHELD
Virtu Financial LLC$1713,7770.00%newNEW
WELLS FARGO & COMPANY/MN$14110.00%2q+175.0%

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q3 202311$201.0K160,7945110.0%
Q2 20239$96.4K79,6339000.0%
Q4 20221$100000100.0%
Q3 20222$12.0K0000100.0%
Q2 20222$36.0K0100100.0%
Q1 20222$124.0K0100100.0%
Q4 20212$31.0K0000100.0%
Q3 20212$61.0K0000100.0%
Q2 20213$587.0K0100100.0%
Q1 20213$937.0K0200100.0%
Q4 20202$236.0K0200100.0%